Evidence map›Paper›PMID 23624917›Full record

ArticleOncogene2014

Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition.

J Park, J E Schwarzbauer

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 241 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Integrin-Piezo1 Axis Drives ECM Remodeling and Invasion of 3D Breast Epithelium.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Regulation of Cancer Stem Cells in the Tumor Microenvironment.Cancer heterogeneity and plasticity · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

J ParkDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.
J E SchwarzbauerDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.
Princeton University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4M
ONCOLOGY: MOLECULAR BASIS OF CANCERT32CA009528 · NCI · PRINCETON UNIVERSITY · PI BROACH, JAMES R. · 1985 to 2010
$5.9M
EXTRACELLULAR MATRIX MODULATION OF CELL PHENOTYPER01GM059383 · NIGMS · PRINCETON UNIVERSITY · PI SCHWARZBAUER, JEAN E · 1999 to 2011
$3.8M
Molecular Analysis of Extracellular Matrix AssemblyR01CA160611 · NCI · PRINCETON UNIVERSITY · PI SCHWARZBAUER, JEAN E · 2012 to 2017
$1.6M
NCI NIH HHS R01 CA160611NCI NIH HHS T32 CA 009528NCI NIH HHS T32 CA009528NIGMS NIH HHS R01 GM059383NIGMS NIH HHS T32 GM007388
6 · The paper itself

Abstract

In the mammary gland, the stromal extracellular matrix (ECM) undergoes dramatic changes during development and in tumorigenesis. For example, normal adult breast tissue is largely devoid of the ECM protein fibronectin (FN) whereas high FN levels have been detected in the stroma of breast tumors. FN is an established marker for epithelial-mesenchymal transition (EMT), which occurs during development and has been linked to cancer. During EMT, epithelial cell adhesion switches from cell-cell contacts to mainly cell-ECM interactions, raising the possibility that FN may have a role in promoting this transition. Using MCF-10A mammary epithelial cells, we show that exposure to exogenous FN induces an EMT response including upregulation of the EMT markers FN, Snail, N-cadherin, vimentin, the matrix metalloprotease MMP2, α-smooth muscle actin and phospho-Smad2, as well as acquisition of cell migratory behavior. FN-induced EMT depends on Src kinase and extracellular signal-regulated kinase/mitogen-activated protein (ERK/MAP) kinase signaling but not on the immediate early gene EGR-1. FN initiates EMT under serum-free conditions; this response is partially reversed by a transforming growth factor (TGF)β-neutralizing antibody, suggesting that FN enhances the effect of endogenous TGFβ. EMT marker expression is upregulated in cells on a fragment of FN containing the integrin-binding domain but not other domains. Differences in gene expression between FN and Matrigel are maintained with addition of a subthreshold level of TGFβ1. Together, these results show that cells interacting with FN are primed to respond to TGFβ. The ability of FN to induce EMT shows an active role for the stromal ECM in this process and supports the notion that the increased levels of FN observed in breast tumors facilitate tumorigenesis.

Indexed as

BreastBreast NeoplasmsCell DifferentiationCells, CulturedEpithelial CellsEpithelial-Mesenchymal TransitionFemaleFibronectinsHumansPhosphorylationSignal TransductionTransforming Growth Factor betaUp-RegulationFibronectinsTransforming Growth Factor beta

Identifiers

PMID23624917
PMCPMC3934944
OpenAlexW1995004906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.